[Suicide gene and immuno gene therapy for prostate cancer].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22208043)

Published in Nihon Rinsho on June 01, 2011

Authors

Yasutomo Nasu1, Katsumi Sasaki, Hiromi Kumon, Haruki Kaku, Masami Watanabe

Author Affiliations

1: Center for Innovative Clinical Medicine, Okayama University Hospital.

Articles by these authors

Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct (2004) 2.28

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol (2005) 1.97

Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res (2007) 1.92

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer. Cancer Immunol Immunother (2010) 1.70

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res (2005) 1.65

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res (2007) 1.61

Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation (2006) 1.60

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int (2010) 1.52

Complete mutation analysis panel of the 39 human HOX genes. Teratology (2002) 1.47

The future of urodynamics: non-invasive ultrasound videourodynamics. Int J Urol (2010) 1.46

High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments. Acta Med Okayama (2004) 1.42

Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol (2008) 1.41

Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol (2002) 1.41

Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res (2008) 1.37

Cooperative roles of vertebrate Fbh1 and Blm DNA helicases in avoidance of crossovers during recombination initiated by replication fork collapse. Mol Cell Biol (2007) 1.36

Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology (2005) 1.35

Description of a 23.9-kilobase chromosomal deletion containing a region encoding fsr genes which mainly determines the gelatinase-negative phenotype of clinical isolates of Enterococcus faecalis in urine. Appl Environ Microbiol (2002) 1.34

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun (2007) 1.34

Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol (2004) 1.33

Phosphorylated histone H2AX foci persist on rejoined mitotic chromosomes in normal human diploid cells exposed to ionizing radiation. Radiat Res (2006) 1.26

Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res (2008) 1.24

Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. J Urol (2004) 1.24

Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation. J Radiat Res (2004) 1.22

Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem (2009) 1.17

Increased chromosome instability and accumulation of DNA double-strand breaks in Werner syndrome cells. J Radiat Res (2007) 1.16

Interplay between DNA polymerases beta and lambda in repair of oxidation DNA damage in chicken DT40 cells. DNA Repair (Amst) (2007) 1.14

Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology (2007) 1.14

Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J (2013) 1.12

Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther (2007) 1.12

Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol (2009) 1.09

Qualitative and quantitative analysis of phosphorylated ATM foci induced by low-dose ionizing radiation. Radiat Res (2006) 1.07

Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J Bacteriol (2008) 1.06

Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol (2002) 1.05

REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med (2007) 1.04

Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol (2003) 1.04

Radiation-induced DNA damage and delayed induced genomic instability. Oncogene (2003) 1.04

Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Med Okayama (2004) 1.04

Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer (2007) 1.03

Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem Biophys Res Commun (2009) 1.03

Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology (2005) 1.02

Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol (2010) 1.01

Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem (2006) 1.01

Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic Biol Med (2003) 1.01

Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther (2009) 1.01

Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer. Prostate (2006) 0.99

Phosphatidylinositol 4,5-bisphosphate stimulates vesicle formation from liposomes by brain cytosol. Proc Natl Acad Sci U S A (2002) 0.99

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer Immun (2003) 0.99

Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol (2005) 0.99

Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. Jpn J Clin Oncol (2004) 0.98

Kidney function after nephrectomy for renal cell carcinoma. Urology (2004) 0.97

Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. DNA Repair (Amst) (2008) 0.97

Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release. Cell Struct Funct (2007) 0.97

Robot-assisted laparoscopic radical prostatectomy in the Asian population: modified port configuration and ultradissection. Int J Urol (2010) 0.96

X-ray-induced telomeric instability in Atm-deficient mouse cells. Biochem Biophys Res Commun (2004) 0.96

DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. J Cell Biol (2010) 0.96

Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. J Infect Chemother (2007) 0.96

Minimal invasiveness and effectivity of subinguinal microscopic varicocelectomy: a comparative study with retroperitoneal high and laparoscopic approaches. Int J Urol (2005) 0.96

Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS One (2011) 0.96

Retroperitoneal schwannoma misdiagnosed as a psoas abscess: report of a case. Surg Today (2002) 0.96

Laparoscopic management of complicated urachal remnants in adults. World J Urol (2012) 0.96

Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol Biotechnol (2014) 0.96

Botulinum toxin type A for the treatment of lower urinary tract disorders. Int J Urol (2012) 0.95

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Med Oncol (2011) 0.95

A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents (2006) 0.95

Long-lived mutagenic radicals induced in mammalian cells by ionizing radiation are mainly localized to proteins. Radiat Res (2003) 0.95

Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama (2004) 0.95

Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair. DNA Repair (Amst) (2006) 0.94

Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci (2004) 0.94

A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats. Exp Neurol (2007) 0.94

Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats. Brain Res (2008) 0.93

Long-term consequence of renal function following nephrectomy for renal cell cancer. Int J Urol (2004) 0.93

miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg. PLoS One (2011) 0.93

Tolerability and morbidity of urodynamic testing: a questionnaire-based study. Urology (2005) 0.93

Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn (2008) 0.92

Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama (2005) 0.92

Interstitial chromatin alteration causes persistent p53 activation involved in the radiation-induced senescence-like growth arrest. Biochem Biophys Res Commun (2005) 0.91

Phosphorylated H2AX foci in tumor cells have no correlation with their radiation sensitivities. J Radiat Res (2009) 0.91

Distribution of dynamins in testis and their possible relation to spermatogenesis. Biochem Biophys Res Commun (2002) 0.91

Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMS. Mutat Res (2009) 0.91

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study. Scand J Urol Nephrol (2009) 0.90

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J Infect Chemother (2013) 0.90

Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer. Int J Oncol (2009) 0.90